IGC Pharma, Inc.

IGC

$0.30

+0.88%

N/A+$0.00

Healthcare

Biotechnology

AMEX

Active Trading

IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a ...

Financial Highlights of IGC

Profitability trend

Latest / TTM · 6 periods

Gross Margin

21.9%

Net Margin

-702.1%

P/E Ratio

-3.63x

n/a

Debt / Equity

0.18

n/a

Current Ratio

0.39

Dividend Yield

0.0%

Understanding

TTM —

Current ratio below 1.0

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

21.9%

Net Margin

-702.1%

P/E Ratio

-3.63x

Debt / Equity

0.18

Profitability

Profitability table

Metric	2022	2023	2024	2025	2026	2026
Gross MarginGross profit as a percentage of revenue.	48.9%	-17.3%	54.5%	48.7%	29.7%	—
Operating MarginOperating income as a percentage of revenue.	-3886.1%	-1270.1%	-728.5%	-585.8%	-860.3%	—
Net MarginNet income as a percentage of revenue.	-3782.4%	-1263.0%	-966.5%	-560.3%	-552.1%	—
EBITDA MarginEBITDA divided by revenue.	-3618.4%	-1190.9%	-919.2%	-523.8%	-524.8%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-3782.4%	-1263.0%	-966.5%	-560.3%	-552.1%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2022	2023	2024	2025	2026	2026
Current RatioCurrent assets divided by current liabilities.	6.19	3.41	1.58	1.28	0.40	—
Quick RatioLiquid assets divided by current liabilities.	4.74	2.01	0.93	0.68	0.18	—
Cash RatioCash and equivalents divided by current liabilities.	4.29	1.68	0.51	0.18	0.07	—
Debt / AssetsDebt as a share of total assets.	2.3%	2.8%	3.5%	2.8%	10.1%	—
Debt / EquityDebt compared with shareholder equity.	0.03	0.03	0.05	0.04	0.15	—

Operating efficiency

Operating efficiency table

Metric	2022	2023	2024	2025	2026	2026
Receivables TurnoverHow often receivables are collected in a year.	0.66x	6.95x	14.78x	16.51x	32.05x	—
Inventory TurnoverHow often inventory is sold in a year.	0.06x	0.40x	0.40x	0.48x	1.31x	—
Payables TurnoverHow often payables are paid in a year.	0.21x	2.02x	0.79x	0.74x	0.66x	—
Asset TurnoverRevenue generated per dollar of assets.	0.01x	0.05x	0.14x	0.15x	0.13x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.02x	0.11x	0.45x	1.27x	-2.18x	—

Valuation ratios

Valuation ratios table

Metric	2022	2023	2024	2025	2026	2026
P/E RatioPrice paid for each dollar of earnings.	-3.16x	-1.54x	-2.16x	-3.06x	-3.64x	—
P/B RatioPrice paid for each dollar of book value.	1.99x	1.20x	3.83x	3.45x	4.08x	—
P/S RatioPrice paid for each dollar of sales.	119.49x	19.59x	20.82x	17.16x	21.08x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-5.76x	-2.33x	-4.90x	-4.13x	-4.09x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

Upstream

Wellness Essentials Northwest Inc.Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)Tandem Clinical ResearchVisionary Investigators Network (VIN)Integrative Clinical Trials, LLCDominion Medical Associates (Lightship Network Site)Kerwin Medical CenterButler Hospital (Care New England Health System)University of South Florida — Department of Psychiatry and Behavioral NeurosciencesPharmaceutical-grade Cannabinoid (THC/CBD) API SuppliersNutraceutical Raw Material Suppliers (Botanicals, Vitamins, Excipients)

Downstream

White-Label / Tolling Manufacturing Clients (Undisclosed)Direct-to-Consumer (DTC) E-commerce CustomersWellness Essentials Northwest Inc.Holiby White-Label / Private-Label Wellness Brand Partners

Proxies

Cassava Sciences, Inc.NASDAQ:SAVA Anavex Life Sciences Corp.NASDAQ:AVXL Canopy Growth CorporationNASDAQ:CGC Jazz Pharmaceuticals plcNASDAQ:JAZZ

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

IGC Pharma, Inc.

Financial Highlights of IGC

Financial highlights

Snapshot

Profitability

Liquidity & leverage

Operating efficiency

Valuation ratios

Supply Chain of IGC

Upstream

Downstream

Proxies

Financial Highlights of IGC

Financial highlights

Snapshot

Profitability

Liquidity & leverage

Operating efficiency

Valuation ratios

Supply Chain of IGC

Upstream

Downstream

Proxies